title: Pulmonary fibrosis in a myeloma patient on bortezomib treatment. A new severe adverse effect of a new drug.
authors.forename: Adrian
authors.initials: A
authors.lastname: Duek
authors.forename: Edith
authors.initials: E
authors.lastname: Feldberg
authors.forename: Michal
authors.initials: M
authors.lastname: Haran
authors.forename: Alain
authors.initials: A
authors.lastname: Berrebi
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects; D001897:Boronic Acids / Q000009:adverse effects*; D000069286:Bortezomib; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D008875:Middle Aged; D009101:Multiple Myeloma / Q000175:diagnosis / Q000188:drug therapy*; D011658:Pulmonary Fibrosis / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy*; D011719:Pyrazines / Q000009:adverse effects*; D012008:Recurrence; D012131:Respiratory Insufficiency / Q000139:chemically induced / Q000188:drug therapy; D013256:Steroids / Q000627:therapeutic use; D017211:Treatment Failure
chemical_list: D000970:Antineoplastic Agents; D001897:Boronic Acids; D011719:Pyrazines; D013256:Steroids; D000069286:Bortezomib